Recombinant Macaca brunnescens NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

What is MT-ND4L and what is its function in cellular metabolism?

MT-ND4L (mitochondrially encoded NADH dehydrogenase 4L) provides instructions for making the NADH dehydrogenase 4L protein, which is a critical subunit of Complex I in the mitochondrial respiratory chain. This protein participates in the first step of the electron transport process during oxidative phosphorylation, specifically in the transfer of electrons from NADH to ubiquinone . The MT-ND4L gene is encoded by the mitochondrial genome rather than nuclear DNA, and its protein product is one of the core hydrophobic subunits that form the transmembrane region of Complex I .

The primary function of MT-ND4L in cellular metabolism is to contribute to energy production through the generation of adenosine triphosphate (ATP). As part of Complex I, it helps create an electrochemical gradient across the inner mitochondrial membrane by pumping protons from the matrix to the intermembrane space. This gradient drives ATP synthesis through ATP synthase (Complex V), completing the oxidative phosphorylation process essential for cellular energy metabolism .

What disease associations have been identified for MT-ND4L mutations?

MT-ND4L mutations have been linked to several mitochondrial disorders, most notably Leber hereditary optic neuropathy (LHON). A specific mutation in MT-ND4L, designated as T10663C or Val65Ala, has been identified in several families with LHON . This mutation substitutes the amino acid valine with alanine at position 65 of the protein .

Beyond LHON, variants of human MT-ND4L have also been associated with increased BMI in adults, suggesting a potential role in metabolic regulation . Additionally, MT-ND4L mutations may contribute to Mitochondrial Complex I deficiency, a disorder that can affect multiple body systems with varying severity .

What methods are used to produce recombinant MT-ND4L for research applications?

Producing recombinant MT-ND4L presents significant challenges due to its highly hydrophobic nature and its natural context within the mitochondrial membrane. Researchers typically employ specialized expression systems optimized for membrane proteins. The following methodology represents current best practices:

• Vector selection: Specialized vectors containing strong promoters (T7, CMV) with appropriate fusion tags (His, GST, or MBP) to aid in purification and solubility.

• Expression systems: Several options depending on research needs:

  • Bacterial systems (E. coli BL21(DE3) or C41/C43 strains designed for membrane proteins)

  • Yeast systems (Pichia pastoris for eukaryotic post-translational modifications)

  • Insect cell systems (Sf9, High Five) using baculovirus vectors

  • Mammalian cell lines for authentic folding and modifications

• Optimization strategies:

  • Reduced temperature during induction (16-25°C)

  • Use of mild detergents (DDM, LDAO, or Fos-choline)

  • Codon optimization for the expression host

  • Addition of solubility-enhancing fusion partners

• Purification protocols:

  • Membrane fraction isolation via differential centrifugation

  • Solubilization with appropriate detergents

  • Affinity chromatography (Ni-NTA for His-tagged constructs)

  • Size exclusion chromatography for final polishing

Commercial sources now provide recombinant MT-ND4L proteins from different Macaca species, including Macaca ochreata and Macaca brunnescens, for research applications .

How are MT-ND4L polymorphisms analyzed in clinical and research settings?

Analysis of MT-ND4L polymorphisms requires specialized methodologies due to the unique characteristics of mitochondrial DNA. Based on recent research approaches, the following methodological framework is recommended:

• Sample collection and DNA extraction:

  • Blood, tissue, or cell samples collected with appropriate ethical approvals

  • DNA extraction using specialized kits that efficiently recover mitochondrial DNA

  • Quantification of mtDNA to ensure adequate template for downstream applications

• Amplification strategies:

  • PCR with primers specific to MT-ND4L gene region

  • Long-range PCR to capture the entire gene and flanking regions

  • Nested PCR approaches for samples with limited mtDNA quantity

• Sequencing methods:

  • Sanger sequencing for targeted analysis of specific polymorphisms

  • Next-generation sequencing for comprehensive mitochondrial genome analysis

  • Pyrosequencing for quantitative assessment of heteroplasmy

• Data analysis approaches:

  • Alignment with reference sequences (revised Cambridge Reference Sequence)

  • Haplogroup assignment to place variants in evolutionary context

  • Prediction of functional impacts using specialized software

  • Statistical assessment of population frequency and disease association

In a recent study investigating potential associations between MT-ND4L polymorphisms and male infertility, researchers employed Sanger sequencing of mitochondrial DNA and identified seven SNPs in MT-ND4L (rs28358280, rs28358281, rs28358279, rs2853487, rs2853488, rs193302933, and rs28532881) . Despite thorough analysis, no statistically significant associations were found between these polymorphisms and male infertility . This methodological approach demonstrates the rigor required for clinical investigations of MT-ND4L variants.

What experimental approaches are used to investigate MT-ND4L function in Complex I?

Investigating the function of MT-ND4L within Complex I requires sophisticated experimental approaches that address both structural and functional aspects:

• Structural analysis techniques:

  • Cryo-electron microscopy for high-resolution structure determination

  • X-ray crystallography (challenging due to membrane protein nature)

  • NMR spectroscopy for dynamic structural elements

  • Molecular dynamics simulations to predict structural interactions

• Functional assays:

  • Complex I activity measurements using spectrophotometric methods

  • Oxygen consumption rate determination using respirometry

  • Membrane potential measurements with fluorescent probes

  • ATP production quantification to assess downstream effects

• Interaction studies:

  • Cross-linking followed by mass spectrometry

  • Co-immunoprecipitation with other Complex I subunits

  • Blue native PAGE for intact complex analysis

  • Proximity labeling approaches (BioID, APEX)

• Genetic manipulation strategies:

  • Cybrid cell models with specific mtDNA mutations

  • CRISPR-based approaches for mitochondrial genome editing

  • Allotopic expression of wild-type or mutant MT-ND4L

  • RNA interference to modulate expression levels

MT-ND4L's position within the core hydrophobic region of Complex I's transmembrane domain makes it particularly important for proton translocation and complex assembly . Research suggests it belongs to the minimal assembly of core proteins required for Complex I function, highlighting its essential role in the respiratory chain .

What is the current understanding of MT-ND4L's role in Leber Hereditary Optic Neuropathy (LHON)?

Leber Hereditary Optic Neuropathy (LHON) is a mitochondrial disorder primarily affecting the optic nerve, leading to sudden vision loss. The T10663C (Val65Ala) mutation in MT-ND4L has been identified in several families with LHON . This mutation changes a single amino acid in the protein, potentially disrupting Complex I function in the mitochondrial inner membrane.

Current understanding of the pathophysiological mechanism suggests that:

• The mutation likely affects the stability or assembly of Complex I

• Disrupted Complex I function may lead to decreased ATP production

• Increased reactive oxygen species (ROS) production may contribute to cellular damage

• Retinal ganglion cells may be particularly vulnerable due to their high energy demands

• Additional genetic and environmental factors likely contribute to the disease phenotype

Despite advances in understanding, researchers have not fully determined how a mutation in MT-ND4L specifically leads to the vision loss characteristic of LHON . The tissue-specific effects remain puzzling, considering that MT-ND4L is expressed in all cells containing mitochondria. This specificity suggests that unique properties of retinal ganglion cells or optic nerve tissue make them particularly vulnerable to disruptions in Complex I function .

How does MT-ND4L contribute to mitochondrial complex I deficiency syndromes?

Mitochondrial complex I deficiency represents a heterogeneous group of disorders resulting from dysfunction of NADH:ubiquinone oxidoreductase (Complex I). Mutations in MT-ND4L can contribute to this phenotype with varying clinical manifestations:

• Biochemical consequences:

  • Reduced Complex I assembly or stability

  • Decreased NADH dehydrogenase activity

  • Impaired electron transfer to ubiquinone

  • Compensatory changes in other respiratory complexes

  • Altered mitochondrial membrane potential

• Cellular effects:

  • Decreased ATP production

  • Increased oxidative stress from electron leakage

  • Disrupted calcium homeostasis

  • Altered mitochondrial dynamics (fission/fusion)

  • Activation of cell death pathways in severe cases

• Tissue manifestations:

  • Preferential involvement of high-energy tissues (brain, muscle, heart)

  • Variable presentations depending on mutation type and heteroplasmy level

  • Progressive accumulation of damage over time

  • Interaction with environmental stressors

  • Potential compensation through mitochondrial biogenesis

While specific MT-ND4L mutations associated with mitochondrial complex I deficiency have been identified, their prevalence appears lower than mutations in other Complex I subunits . The highly hydrophobic nature of MT-ND4L and its central position in the membrane domain of Complex I suggests that mutations may significantly impair proton pumping activity, disrupting the electrochemical gradient necessary for ATP production .

Is there evidence for MT-ND4L involvement in reproductive disorders?

Research has investigated potential associations between MT-ND4L polymorphisms and reproductive disorders, particularly male infertility. A recent study examined this relationship by performing Sanger sequencing of mitochondrial DNA in 68 subfertile and 44 fertile males .

The researchers identified seven single nucleotide polymorphisms (SNPs) in MT-ND4L:

• rs28358280

• rs28358281

• rs28358279

• rs2853487

• rs2853488

• rs193302933

• rs28532881

• Asthenozoospermia

• Oligozoospermia

• Teratozoospermia

• Asthenoteratozoospermia

• Oligoasthenoteratozoospermia

• Oligoteratozoospermia

While this particular study did not support a role for MT-ND4L in male infertility, it's important to note that the researchers called for further investigations to evaluate these findings more thoroughly . Mitochondrial function is critical for sperm motility and energy production, suggesting that larger studies with different populations or methodological approaches might reveal associations not detected in this initial investigation.

What model systems are most appropriate for studying MT-ND4L function?

Selecting appropriate model systems for MT-ND4L research requires consideration of experimental objectives, technical feasibility, and physiological relevance:

• Cellular models:

  • Transmitochondrial cybrid cells (human cell lines with patient-derived mitochondria)

  • Fibroblasts derived from patients with MT-ND4L mutations

  • Induced pluripotent stem cells (iPSCs) and differentiated derivatives

  • Established cell lines with modified mtDNA (143B, HEK293, etc.)

• Non-mammalian models:

  • Saccharomyces cerevisiae (lacks some Complex I components but useful for some studies)

  • Neurospora crassa (contains Complex I similar to mammals)

  • Caenorhabditis elegans (transparent, genetic tractability, short lifespan)

  • Drosophila melanogaster (genetic tools, complex tissues, relatively short lifespan)

• Mammalian models:

  • Mouse models (limited by differences in mitochondrial genetics)

  • Non-human primates (Macaca species provide closer evolutionary relationship to humans)

  • Transmitochondrial mice (containing human mtDNA with specific mutations)

• In vitro systems:

  • Reconstituted Complex I from purified components

  • Isolated mitochondria from relevant tissues

  • Submitochondrial particles for functional assays

  • Liposome-reconstituted systems for transport studies

When working with recombinant MT-ND4L from Macaca species, researchers should consider the evolutionary conservation of this protein. Macaca brunnescens and Macaca ochreata MT-ND4L share high sequence similarity with human MT-ND4L, making them valuable models for studying human mitochondrial disorders . The commercial availability of recombinant proteins from these species facilitates comparative studies across primate lineages.

What are the challenges and solutions for working with highly hydrophobic proteins like MT-ND4L?

MT-ND4L presents significant technical challenges due to its highly hydrophobic nature and membrane localization. Researchers have developed specific strategies to address these difficulties:

• Expression challenges and solutions:

  Challenge	Solution Approach
  Toxicity to expression host	Use of specialized strains (C41/C43)
  Poor expression yield	Codon optimization, reduced temperature
  Inclusion body formation	Fusion with solubility tags (MBP, SUMO)
  Improper folding	Expression in eukaryotic systems
  Degradation	Protease inhibitors, lower induction temperature

• Purification challenges and solutions:

  Challenge	Solution Approach
  Detergent selection	Screening mild detergents (DDM, LDAO, etc.)
  Protein aggregation	Addition of stabilizing lipids or amphipols
  Low recovery	Optimized extraction conditions and buffer composition
  Purity assessment	Specialized SDS-PAGE systems for membrane proteins
  Activity loss	Reconstitution into nanodiscs or liposomes

• Structural analysis challenges and solutions:

  Challenge	Solution Approach
  Crystal formation	Lipidic cubic phase crystallization
  NMR signal resolution	Selective isotopic labeling strategies
  Sample heterogeneity	Single-particle cryo-EM approaches
  Conformational flexibility	Cross-linking to stabilize specific states
  Model building	Integration with computational prediction methods

• Functional analysis challenges and solutions:

  Challenge	Solution Approach
  Activity measurement	Specialized assays for membrane-embedded enzymes
  Interaction mapping	Chemical cross-linking with mass spectrometry
  Physiological relevance	Integration into model membrane systems
  Signal detection	Sensitive fluorescent or electrochemical methods
  Data interpretation	Comparative analysis with related proteins

When specifically working with recombinant Macaca MT-ND4L, researchers should consider species-specific optimization of expression conditions while leveraging the evolutionary conservation to apply findings from model systems to human health applications .

How can researchers effectively measure MT-ND4L activity in experimental settings?

• Spectrophotometric assays:

  • NADH oxidation measurement (absorbance decrease at 340 nm)

  • Artificial electron acceptor reduction (DCIP, ferricyanide)

  • Ubiquinone reduction monitoring (coenzyme Q1 or decylubiquinone)

  • Coupled assays with other electron transport chain components

• Respirometry approaches:

  • Oxygen consumption measurement using oxygen electrodes

  • High-resolution respirometry with substrate-inhibitor titrations

  • Seahorse XF analysis for cellular oxygen consumption rate

  • Simultaneous measurement of membrane potential

• Proton pumping assessment:

  • pH-sensitive dye-based measurements

  • Ion-selective electrodes for proton translocation

  • Reconstituted systems with pH indicators inside vesicles

  • Patch-clamp electrophysiology for direct current measurement

• Structural integrity evaluation:

  • Blue native PAGE to assess Complex I assembly

  • Immunodetection of MT-ND4L and interacting subunits

  • Cross-linking followed by mass spectrometry

  • Thermal stability assays to detect structural perturbations

When evaluating MT-ND4L variants or mutations, comparative analysis with wild-type protein is essential. This typically involves creating cell lines with different variants and measuring differences in Complex I activity, assembly, and stability. For recombinant proteins, reconstitution into proteoliposomes or nanodiscs can provide a controlled environment for functional assessments .

What are emerging approaches for studying MT-ND4L's role in mitochondrial diseases?

Emerging research approaches are expanding our understanding of MT-ND4L's role in mitochondrial diseases:

• Advanced genetic technologies:

  • Mitochondrial genome editing with modified CRISPR systems

  • Base editing technologies for precise mtDNA modification

  • RNA-based therapies to compensate for mtDNA mutations

  • Allotopic expression of engineered MT-ND4L variants

• Single-cell technologies:

  • Single-cell proteomics to analyze Complex I composition

  • Single-cell metabolomics for functional heterogeneity assessment

  • Spatial transcriptomics to map tissue-specific effects

  • Live-cell imaging of mitochondrial dynamics and function

• Multi-omics integration:

  • Combined genomic, transcriptomic, proteomic, and metabolomic analyses

  • Network biology approaches to understand system-wide effects

  • Machine learning for pattern recognition in complex datasets

  • Pathway analysis to identify compensatory mechanisms

• Translational applications:

  • Patient-derived organoids for personalized medicine approaches

  • Tissue-specific models of MT-ND4L dysfunction

  • Development of small molecule modulators of Complex I

  • Mitochondrial replacement therapy for prevention of transmission

Future research will likely focus on understanding the precise molecular mechanisms by which MT-ND4L mutations lead to tissue-specific pathologies, particularly in conditions like LHON . Additionally, the overlap between MT-ND4L and MT-ND4 genes presents interesting questions about the co-evolution and coordinated expression of these genes that warrant further investigation .

How might comparative studies of MT-ND4L across primate species advance our understanding of mitochondrial function?

Comparative studies of MT-ND4L across primate species offer valuable insights into evolutionary conservation, functional constraints, and potential therapeutic approaches:

• Evolutionary insights:

  • Identification of highly conserved residues critical for function

  • Mapping of species-specific adaptations to metabolic demands

  • Understanding selection pressures on mitochondrial genes

  • Correlation between genetic variations and phenotypic differences

• Functional implications:

  • Analysis of naturally occurring variants that alter activity

  • Identification of compensatory mutations that maintain function

  • Assessment of substrate specificity differences across species

  • Evaluation of interaction patterns with nuclear-encoded subunits

• Methodological advantages:

  • Utilization of recombinant proteins from multiple species (Macaca ochreata, Macaca brunnescens)

  • Cross-species complementation studies to test functional conservation

  • Creation of chimeric proteins to map functional domains

  • Development of antibodies with variable species specificity

• Therapeutic relevance:

  • Identification of natural variants with protective effects

  • Understanding the basis for variable penetrance of mutations

  • Development of species-specific models for human diseases

  • Testing therapeutic approaches across primate models

The availability of recombinant MT-ND4L proteins from different Macaca species provides researchers with valuable tools for comparative studies . These studies can help identify regions of the protein that tolerate variation versus those that are functionally constrained, potentially guiding the development of therapeutic approaches for mitochondrial disorders associated with MT-ND4L mutations.